1
Documento Autorizaciขn Centro Empleador
Loading dashboard...
Monthly Trend View
Showing click-to-open rate across the period. This is clicks divided by opens, so it shows how well opened emails convert into clicks.
Country + Brand + Time Breakdowns
Breakdown Explorer
One focused view at a time for faster scanning.
Rows
102
Sent
66,849
Open Rate
34.2%
CTR
7.6%
Top Countries
🇪🇸 Spain
28,024
Open 45.4% · CTR 10.5%
🇮🇹 Italy
18,329
Open 22.6% · CTR 3.5%
🇬🇧 United Kingdom
6,808
Open 30.0% · CTR 8.0%
🇫🇷 France
4,981
Open 32.2% · CTR 5.3%
🇩🇪 Germany
4,377
Open 32.5% · CTR 8.1%
🇨🇭 Switzerland
1,663
Open 19.0% · CTR 5.4%
| Month | Country | Sent | Open Rate | CTR |
|---|---|---|---|---|
| Sept 25 | 🇪🇸 Spain | 8,804 | 48.0% | 11.6% |
| Apr 26 | 🇮🇹 Italy | 8,290 | 19.0% | 1.8% |
| Oct 25 | 🇪🇸 Spain | 6,812 | 48.6% | 6.9% |
| Sept 25 | 🇮🇹 Italy | 4,126 | 39.4% | 7.1% |
| Sept 25 | 🇬🇧 United Kingdom | 3,497 | 30.4% | 9.6% |
| Sept 25 | 🇫🇷 France | 2,880 | 25.7% | 5.9% |
| Mar 26 | 🇪🇸 Spain | 2,596 | 45.1% | 11.2% |
| Feb 26 | 🇪🇸 Spain | 2,477 | 48.0% | 17.2% |
| Dec 25 | 🇪🇸 Spain | 2,466 | 37.1% | 3.4% |
| Nov 25 | 🇮🇹 Italy | 2,239 | 5.9% | 0.9% |
| Nov 25 | 🇪🇸 Spain | 2,226 | 38.4% | 6.6% |
| Dec 25 | 🇮🇹 Italy | 1,968 | 5.5% | 0.7% |
| Apr 26 | 🇬🇧 United Kingdom | 1,366 | 25.7% | 3.4% |
| Apr 26 | 🇪🇸 Spain | 1,336 | 43.8% | 22.9% |
Showing 14 of 102 rows
Highest performing emails (min sent 100)
Highest2
Reuniones Online Consent - 2
3
Approved Email Consent - 2
4
Spain - Consent Email 1 Aug 25
5
Austria - Consent Email - Aug25 v2
6
PSIQUIATRÍA - Guía de Manejo Psicoterapéutico
7
AEESME 2026: Programa simposio
8
Libro IA en psiquiatría
Lowest performing emails (min sent 100)
Lowest1
RXULTI - Recordatorio webinar Neurociencias lanzamiento indicación adolescente
RexultiES
Sent
127
Open Rate
0.0%
CTR
0.0%
2
SE_Webinarserie_AdvancesinSchizophrenia_preapproved
3
SE_Webinar_DavidTaylor_November_preapproved
4
ALL_Kassenzulässigkeit_960mg_2025_AM_fr
5
Rxulti dem 2
6
LUP - Invitación webinar "The importance of proteinuria management" - nefro
LupkynisES
Sent
185
Open Rate
5.9%
CTR
0.0%
7
LDM P2P Invite 23-Apr-26 [digital]
8
ALL_Gegenüberstellung_400mg/960mg_2026_AM_AA_fr
VEEVA Email Library
Email cards
Performance metrics and engagement data for each approved email in your current filter.
410 records
UnbrandedES
Sent
5,772
Opened
2,873
Clicked
623
Open / CTR
49.8%/10.8%
Positive
0
Negative
0
Email #2
Rxulti dem 2RexultiIT
Sent
3,407
Opened
12
Clicked
1
Open / CTR
0.4%/0.0%
Positive
0
Negative
0
Email #3
OPUK HCP Survey Email June 2025UnbrandedGB, IE
Sent
2,755
Opened
820
Clicked
258
Open / CTR
29.8%/9.4%
Positive
0
Negative
0
Email #4
Rxulti DEM 3RexultiIT
Sent
2,608
Opened
448
Clicked
22
Open / CTR
17.2%/0.8%
Positive
0
Negative
0
UnspecifiedIT
Sent
2,494
Opened
589
Clicked
55
Open / CTR
23.6%/2.2%
Positive
0
Negative
0
UnbrandedFR
Sent
2,493
Opened
569
Clicked
153
Open / CTR
22.8%/6.1%
Positive
0
Negative
0
Email #7
Rxulti DEM 4RexultiIT
Sent
2,460
Opened
371
Clicked
23
Open / CTR
15.1%/0.9%
Positive
0
Negative
0
RexultiES
Sent
2,147
Opened
1,125
Clicked
72
Open / CTR
52.4%/3.4%
Positive
22
Negative
13
UnbrandedIT
Sent
1,952
Opened
672
Clicked
132
Open / CTR
34.4%/6.8%
Positive
0
Negative
0
Email #10
AE MasterclassAbilify MaintenaIT
Sent
1,941
Opened
841
Clicked
140
Open / CTR
43.3%/7.2%
Positive
43
Negative
27
RexultiES
Sent
1,550
Opened
847
Clicked
79
Open / CTR
54.6%/5.1%
Positive
0
Negative
0
Email #12
DACH (DE) HCP NPS Survey VAE 2025UnbrandedDE
Sent
1,103
Opened
442
Clicked
168
Open / CTR
40.1%/15.2%
Positive
0
Negative
0
LupkynisES
Sent
876
Opened
351
Clicked
44
Open / CTR
40.1%/5.0%
Positive
0
Negative
0
Email #14
Libro IA en psiquiatríaRexultiES
Sent
784
Opened
405
Clicked
150
Open / CTR
51.7%/19.1%
Positive
0
Negative
0
UnbrandedES
Sent
768
Opened
667
Clicked
601
Open / CTR
86.8%/78.3%
Positive
0
Negative
0
LupkynisES
Sent
677
Opened
219
Clicked
35
Open / CTR
32.3%/5.2%
Positive
0
Negative
0
LupkynisES
Sent
660
Opened
239
Clicked
29
Open / CTR
36.2%/4.4%
Positive
0
Negative
0
Abilify MaintenaDE
Sent
656
Opened
191
Clicked
33
Open / CTR
29.1%/5.0%
Positive
0
Negative
0
Abilify MaintenaFR
Sent
655
Opened
248
Clicked
7
Open / CTR
37.9%/1.1%
Positive
0
Negative
0
Abilify MaintenaGB
Sent
576
Opened
165
Clicked
60
Open / CTR
28.6%/10.4%
Positive
0
Negative
0
Email #21
INVITATION_VAD_2023UnbrandedFR
Sent
565
Opened
287
Clicked
0
Open / CTR
50.8%/0.0%
Positive
0
Negative
0
Email #22
ES Veeva Privacy Notice EmailUnbrandedES, PT, RO
Sent
551
Opened
279
Clicked
17
Open / CTR
50.6%/3.1%
Positive
0
Negative
0
Email #23
Postal Navidad 2025RexultiES
Sent
538
Opened
318
Clicked
3
Open / CTR
59.1%/0.6%
Positive
0
Negative
0
Email #24
LDM DR P2P Invite 25-Nov [digital]Abilify MaintenaGB
Sent
517
Opened
152
Clicked
1
Open / CTR
29.4%/0.2%
Positive
0
Negative
0
Abilify MaintenaDE
Sent
509
Opened
158
Clicked
28
Open / CTR
31.0%/5.5%
Positive
0
Negative
0
LupkynisES
Sent
503
Opened
186
Clicked
39
Open / CTR
37.0%/7.8%
Positive
0
Negative
0
Email #27
NL AE HCP PortalAbilify MaintenaIT
Sent
497
Opened
192
Clicked
45
Open / CTR
38.6%/9.1%
Positive
0
Negative
0
InaqoviES
Sent
468
Opened
190
Clicked
42
Open / CTR
40.6%/9.0%
Positive
0
Negative
0
Abilify MaintenaGB
Sent
452
Opened
55
Clicked
3
Open / CTR
12.2%/0.7%
Positive
0
Negative
0
LupkynisES
Sent
437
Opened
83
Clicked
5
Open / CTR
19.0%/1.1%
Positive
1
Negative
2
LupkynisES
Sent
412
Opened
144
Clicked
17
Open / CTR
35.0%/4.1%
Positive
0
Negative
0
Email #32
Aripiprazole 960mg FAQ VAEAbilify MaintenaGB
Sent
412
Opened
98
Clicked
14
Open / CTR
23.8%/3.4%
Positive
0
Negative
0
LupkynisES
Sent
402
Opened
157
Clicked
32
Open / CTR
39.1%/8.0%
Positive
0
Negative
0
Email #34
DACH (CH de) HCP NPS Survey VAE 2025UnbrandedCH, DE
Sent
401
Opened
164
Clicked
55
Open / CTR
40.9%/13.7%
Positive
0
Negative
0
LupkynisES
Sent
397
Opened
54
Clicked
5
Open / CTR
13.6%/1.3%
Positive
1
Negative
1
LupkynisES
Sent
379
Opened
51
Clicked
5
Open / CTR
13.5%/1.3%
Positive
0
Negative
0
Email #37
AM960 VAE DE - Weihnachtsgrüße 2025Abilify MaintenaDE
Sent
379
Opened
122
Clicked
7
Open / CTR
32.2%/1.8%
Positive
0
Negative
0
Email #38
SF P2P Invite 12-Feb-26 [digital]Abilify MaintenaGB
Sent
379
Opened
102
Clicked
26
Open / CTR
26.9%/6.9%
Positive
0
Negative
0
LupkynisES
Sent
342
Opened
169
Clicked
20
Open / CTR
49.4%/5.8%
Positive
0
Negative
0
Abilify MaintenaCH
Sent
327
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
Abilify MaintenaCH
Sent
321
Opened
13
Clicked
12
Open / CTR
4.0%/3.7%
Positive
0
Negative
0
UnbrandedSE
Sent
320
Opened
65
Clicked
18
Open / CTR
20.3%/5.6%
Positive
0
Negative
0
Abilify MaintenaGB
Sent
320
Opened
70
Clicked
2
Open / CTR
21.9%/0.6%
Positive
0
Negative
0
Email #44
LUP - Congreso EAS- SER 2026 - nefroLupkynisES
Sent
319
Opened
107
Clicked
8
Open / CTR
33.5%/2.5%
Positive
0
Negative
0
Email #45
SEPD 2026: Programa simpoUnspecifiedES
Sent
313
Opened
127
Clicked
21
Open / CTR
40.6%/6.7%
Positive
0
Negative
0
Email #46
Reuniones Online Consent - 2UnbrandedES
Sent
311
Opened
251
Clicked
217
Open / CTR
80.7%/69.8%
Positive
0
Negative
0
Abilify MaintenaDE
Sent
310
Opened
114
Clicked
12
Open / CTR
36.8%/3.9%
Positive
0
Negative
0
Email #48
LUP-Material riñones CLMLupkynisES
Sent
304
Opened
110
Clicked
47
Open / CTR
36.2%/15.5%
Positive
0
Negative
0
Abilify MaintenaFR
Sent
297
Opened
99
Clicked
5
Open / CTR
33.3%/1.7%
Positive
0
Negative
0
LupkynisES
Sent
293
Opened
105
Clicked
20
Open / CTR
35.8%/6.8%
Positive
0
Negative
0
LupkynisES
Sent
292
Opened
135
Clicked
7
Open / CTR
46.2%/2.4%
Positive
0
Negative
0
LupkynisES
Sent
292
Opened
128
Clicked
20
Open / CTR
43.8%/6.8%
Positive
0
Negative
0
UnspecifiedDE
Sent
292
Opened
61
Clicked
11
Open / CTR
20.9%/3.8%
Positive
0
Negative
0
LupkynisES
Sent
282
Opened
100
Clicked
4
Open / CTR
35.5%/1.4%
Positive
0
Negative
0
Email #55
LUP - Invitación webinar 13N - nefroLupkynisES
Sent
275
Opened
89
Clicked
5
Open / CTR
32.4%/1.8%
Positive
0
Negative
0
InaqoviES
Sent
269
Opened
80
Clicked
9
Open / CTR
29.7%/3.3%
Positive
1
Negative
0
Abilify MaintenaES
Sent
268
Opened
155
Clicked
23
Open / CTR
57.8%/8.6%
Positive
0
Negative
0
Email #58
REMERCIEMENTS_VAD_2023UnbrandedFR
Sent
266
Opened
129
Clicked
14
Open / CTR
48.5%/5.3%
Positive
0
Negative
0
InaqoviES
Sent
258
Opened
83
Clicked
8
Open / CTR
32.2%/3.1%
Positive
0
Negative
0
LupkynisES
Sent
257
Opened
91
Clicked
4
Open / CTR
35.4%/1.6%
Positive
0
Negative
0
UnbrandedFI
Sent
256
Opened
48
Clicked
16
Open / CTR
18.8%/6.3%
Positive
0
Negative
0
Abilify MaintenaIT
Sent
249
Opened
100
Clicked
13
Open / CTR
40.2%/5.2%
Positive
4
Negative
0
RexultiES
Sent
247
Opened
61
Clicked
2
Open / CTR
24.7%/0.8%
Positive
2
Negative
0
InaqoviES
Sent
245
Opened
83
Clicked
4
Open / CTR
33.9%/1.6%
Positive
3
Negative
1
Email #65
AE SAVE THE DATE CONGRESSO SIRLupkynisIT
Sent
245
Opened
35
Clicked
1
Open / CTR
14.3%/0.4%
Positive
0
Negative
0
RexultiES
Sent
234
Opened
129
Clicked
15
Open / CTR
55.1%/6.4%
Positive
1
Negative
1
InaqoviES
Sent
231
Opened
60
Clicked
6
Open / CTR
26.0%/2.6%
Positive
3
Negative
3
LupkynisGB
Sent
223
Opened
99
Clicked
3
Open / CTR
44.4%/1.3%
Positive
0
Negative
0
Email #69
Spain - Consent Email 1 Aug 25UnbrandedES
Sent
215
Opened
148
Clicked
120
Open / CTR
68.8%/55.8%
Positive
0
Negative
0
RexultiES
Sent
212
Opened
106
Clicked
32
Open / CTR
50.0%/15.1%
Positive
1
Negative
0
Email #71
PSIQUIATRÍA - Programas ECNP 2025RexultiES
Sent
206
Opened
138
Clicked
15
Open / CTR
67.0%/7.3%
Positive
0
Negative
0
LupkynisES
Sent
201
Opened
83
Clicked
7
Open / CTR
41.3%/3.5%
Positive
0
Negative
0
Abilify MaintenaES
Sent
193
Opened
107
Clicked
4
Open / CTR
55.4%/2.1%
Positive
0
Negative
0
LupkynisES
Sent
191
Opened
38
Clicked
2
Open / CTR
19.9%/1.0%
Positive
0
Negative
0
Abilify MaintenaSE
Sent
191
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
RexultiES
Sent
187
Opened
113
Clicked
24
Open / CTR
60.4%/12.8%
Positive
0
Negative
0
LupkynisES
Sent
185
Opened
11
Clicked
0
Open / CTR
5.9%/0.0%
Positive
0
Negative
0
LupkynisGB, IE
Sent
180
Opened
79
Clicked
35
Open / CTR
43.9%/19.4%
Positive
0
Negative
0
Abilify MaintenaES
Sent
168
Opened
90
Clicked
12
Open / CTR
53.6%/7.1%
Positive
0
Negative
0
Abilify MaintenaIT
Sent
168
Opened
42
Clicked
10
Open / CTR
25.0%/6.0%
Positive
0
Negative
0
LupkynisES
Sent
167
Opened
59
Clicked
3
Open / CTR
35.3%/1.8%
Positive
0
Negative
0
Abilify MaintenaCH
Sent
165
Opened
25
Clicked
6
Open / CTR
15.2%/3.6%
Positive
0
Negative
0
Abilify MaintenaIT
Sent
164
Opened
75
Clicked
10
Open / CTR
45.7%/6.1%
Positive
1
Negative
0
Email #84
ENFERMERÍA - PODCAST: Ep4 SueñoRexultiES
Sent
162
Opened
54
Clicked
5
Open / CTR
33.3%/3.1%
Positive
0
Negative
0
UnbrandedNO
Sent
161
Opened
44
Clicked
15
Open / CTR
27.3%/9.3%
Positive
0
Negative
0
Email #86
Aripiprazole 960mg Fragment VAEAbilify MaintenaGB
Sent
160
Opened
46
Clicked
30
Open / CTR
28.7%/18.8%
Positive
0
Negative
0
Abilify MaintenaES
Sent
153
Opened
63
Clicked
12
Open / CTR
41.2%/7.8%
Positive
0
Negative
0
Email #88
Approved Email Consent - 2UnbrandedES
Sent
153
Opened
122
Clicked
106
Open / CTR
79.7%/69.3%
Positive
0
Negative
0
RexultiSE
Sent
150
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
Email #90
IT Veeva Privacy Notice EmailUnbrandedIT
Sent
144
Opened
43
Clicked
4
Open / CTR
29.9%/2.8%
Positive
0
Negative
0
Email #91
LUP - Poster Deep Response - nefroLupkynisES
Sent
143
Opened
24
Clicked
3
Open / CTR
16.8%/2.1%
Positive
0
Negative
0
Email #92
AE SAVE THE DATE CONGRESSO SINLupkynisIT
Sent
141
Opened
58
Clicked
0
Open / CTR
41.1%/0.0%
Positive
0
Negative
0
LupkynisGB
Sent
140
Opened
63
Clicked
1
Open / CTR
45.0%/0.7%
Positive
0
Negative
0
Email #94
ENFERMERÍA - Revista Peplau nº5Abilify MaintenaES
Sent
136
Opened
70
Clicked
15
Open / CTR
51.5%/11.0%
Positive
0
Negative
0
LupkynisIT
Sent
136
Opened
38
Clicked
3
Open / CTR
27.9%/2.2%
Positive
1
Negative
1
RexultiES
Sent
133
Opened
79
Clicked
36
Open / CTR
59.4%/27.1%
Positive
5
Negative
1
Abilify MaintenaES
Sent
132
Opened
78
Clicked
11
Open / CTR
59.1%/8.3%
Positive
0
Negative
0
Email #98
FR-AM2-2500027Abilify MaintenaFR
Sent
131
Opened
29
Clicked
4
Open / CTR
22.1%/3.1%
Positive
0
Negative
0
RexultiES
Sent
130
Opened
71
Clicked
8
Open / CTR
54.6%/6.2%
Positive
0
Negative
0
LupkynisIT
Sent
130
Opened
41
Clicked
4
Open / CTR
31.5%/3.1%
Positive
2
Negative
0
Email #101
Emailing Brochures aidants et patientsAbilify MaintenaFR
Sent
129
Opened
60
Clicked
12
Open / CTR
46.5%/9.3%
Positive
0
Negative
0
Email #102
RXULTI - Comparativa antipsicóticosRexultiES
Sent
128
Opened
57
Clicked
6
Open / CTR
44.5%/4.7%
Positive
1
Negative
0
RexultiES
Sent
128
Opened
57
Clicked
6
Open / CTR
44.5%/4.7%
Positive
0
Negative
0
RexultiES
Sent
127
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
Email #105
AEESME 2026: Programa simposioAbilify MaintenaES, RO
Sent
123
Opened
51
Clicked
38
Open / CTR
41.5%/30.9%
Positive
0
Negative
0
Email #106
Austria - Consent Email - Aug25 v2UnbrandedAT
Sent
122
Opened
57
Clicked
46
Open / CTR
46.7%/37.7%
Positive
0
Negative
0
InaqoviDE
Sent
121
Opened
28
Clicked
5
Open / CTR
23.1%/4.1%
Positive
0
Negative
0
Email #108
LUP - Invitación webinar 13N - reumaLupkynisES
Sent
118
Opened
20
Clicked
2
Open / CTR
16.9%/1.7%
Positive
0
Negative
0
Email #109
Otsuka Privacy Notice - UK (v2)UnbrandedCZ, GB, GR, HR, IE, TR, ZZ
Sent
117
Opened
50
Clicked
4
Open / CTR
42.7%/3.4%
Positive
0
Negative
0
LupkynisIT
Sent
116
Opened
37
Clicked
3
Open / CTR
31.9%/2.6%
Positive
1
Negative
1
UnbrandedDK
Sent
115
Opened
29
Clicked
6
Open / CTR
25.2%/5.2%
Positive
0
Negative
0
LupkynisGB
Sent
113
Opened
51
Clicked
26
Open / CTR
45.1%/23.0%
Positive
0
Negative
0
Email #113
LDM P2P Invite 23-Apr-26 [digital]Abilify MaintenaGB
Sent
111
Opened
10
Clicked
0
Open / CTR
9.0%/0.0%
Positive
0
Negative
0
Email #114
INA - VAE Videos Simposio SEHH 2025InaqoviES
Sent
109
Opened
43
Clicked
19
Open / CTR
39.4%/17.4%
Positive
0
Negative
0
Abilify MaintenaES
Sent
107
Opened
53
Clicked
12
Open / CTR
49.5%/11.2%
Positive
0
Negative
0
LupkynisIT
Sent
103
Opened
27
Clicked
3
Open / CTR
26.2%/2.9%
Positive
0
Negative
0
Email #117
LUP - Congreso EAS- SER 2026 - reumaLupkynisES
Sent
102
Opened
27
Clicked
2
Open / CTR
26.5%/2.0%
Positive
0
Negative
0
Abilify MaintenaES
Sent
101
Opened
54
Clicked
4
Open / CTR
53.5%/4.0%
Positive
6
Negative
0
LupkynisIT
Sent
101
Opened
32
Clicked
1
Open / CTR
31.7%/1.0%
Positive
0
Negative
0
Email #120
DEM MUTAZIONE tp53InaqoviIT
Sent
98
Opened
25
Clicked
3
Open / CTR
25.5%/3.1%
Positive
0
Negative
0
Email #121
INA VAE DE - Einladung DGHO 2025InaqoviDE
Sent
97
Opened
30
Clicked
4
Open / CTR
30.9%/4.1%
Positive
2
Negative
3
Email #122
Postal Navidad 2025 - INAQOVIInaqoviES
Sent
96
Opened
36
Clicked
1
Open / CTR
37.5%/1.0%
Positive
0
Negative
0
LupkynisES
Sent
94
Opened
23
Clicked
2
Open / CTR
24.5%/2.1%
Positive
0
Negative
0
UnspecifiedFR
Sent
94
Opened
40
Clicked
9
Open / CTR
42.6%/9.6%
Positive
0
Negative
0
LupkynisIT
Sent
93
Opened
23
Clicked
1
Open / CTR
24.7%/1.1%
Positive
1
Negative
1
UnbrandedAT
Sent
92
Opened
45
Clicked
34
Open / CTR
48.9%/37.0%
Positive
0
Negative
0
LupkynisES
Sent
91
Opened
52
Clicked
21
Open / CTR
57.1%/23.1%
Positive
0
Negative
0
LupkynisES
Sent
91
Opened
33
Clicked
5
Open / CTR
36.3%/5.5%
Positive
0
Negative
0
Email #129
LDM P2P Invite 7-Oct [digital]Abilify MaintenaGB
Sent
91
Opened
35
Clicked
2
Open / CTR
38.5%/2.2%
Positive
0
Negative
0
Abilify MaintenaCH
Sent
89
Opened
1
Clicked
0
Open / CTR
1.1%/0.0%
Positive
0
Negative
0
Email #131
France - Opt In Email Aug 25 v2UnbrandedFR, GP, RE
Sent
87
Opened
31
Clicked
25
Open / CTR
35.6%/28.7%
Positive
0
Negative
0
Email #132
DACH (CH fr) HCP NPS Survey VAE 2025UnbrandedCH, DE
Sent
83
Opened
40
Clicked
8
Open / CTR
48.2%/9.6%
Positive
0
Negative
0
Email #133
FI AM2 VAE 720mg TUU FI-AM2-2500020Abilify MaintenaFI
Sent
83
Opened
15
Clicked
4
Open / CTR
18.1%/4.8%
Positive
8
Negative
8
Email #134
IT ToV Veeva Privacy Notice EmailUnbrandedIT
Sent
81
Opened
34
Clicked
3
Open / CTR
42.0%/3.7%
Positive
0
Negative
0
Email #135
DACH (AT) HCP NPS Survey VAE 2025UnbrandedAT, DE
Sent
80
Opened
18
Clicked
11
Open / CTR
22.5%/13.8%
Positive
0
Negative
0
UnbrandedAT
Sent
79
Opened
43
Clicked
28
Open / CTR
54.4%/35.4%
Positive
0
Negative
0
Abilify MaintenaDE
Sent
78
Opened
28
Clicked
2
Open / CTR
35.9%/2.6%
Positive
0
Negative
0
Abilify MaintenaES
Sent
75
Opened
45
Clicked
5
Open / CTR
60.0%/6.7%
Positive
0
Negative
0
InaqoviDE
Sent
75
Opened
3
Clicked
0
Open / CTR
4.0%/0.0%
Positive
5
Negative
5
InaqoviDE
Sent
75
Opened
9
Clicked
3
Open / CTR
12.0%/4.0%
Positive
0
Negative
0
Email #141
SE_Stabilitet över tid 960mg_preapprovedAbilify MaintenaSE
Sent
71
Opened
2
Clicked
0
Open / CTR
2.8%/0.0%
Positive
0
Negative
0
InaqoviDE
Sent
70
Opened
25
Clicked
6
Open / CTR
35.7%/8.6%
Positive
0
Negative
0
LupkynisCH
Sent
70
Opened
25
Clicked
2
Open / CTR
35.7%/2.9%
Positive
0
Negative
0
Email #144
INA VAE DE – EL DKK 2026 BerlinInaqoviDE
Sent
69
Opened
17
Clicked
4
Open / CTR
24.6%/5.8%
Positive
0
Negative
0
Email #145
VAE DE AM960 - Podcast_Köhler_1025Abilify MaintenaDE
Sent
68
Opened
35
Clicked
10
Open / CTR
51.5%/14.7%
Positive
0
Negative
0
LupkynisIT
Sent
68
Opened
17
Clicked
1
Open / CTR
25.0%/1.5%
Positive
1
Negative
1
Email #147
INA VAE DE - Leitlinienhinweis INAQOVIInaqoviDE
Sent
67
Opened
12
Clicked
7
Open / CTR
17.9%/10.4%
Positive
0
Negative
0
Email #148
Invitación IX Jornada UHB 2025Abilify MaintenaES
Sent
66
Opened
43
Clicked
22
Open / CTR
65.2%/33.3%
Positive
0
Negative
0
LupkynisAT
Sent
66
Opened
14
Clicked
10
Open / CTR
21.2%/15.2%
Positive
0
Negative
0
Abilify MaintenaDE
Sent
64
Opened
23
Clicked
4
Open / CTR
35.9%/6.3%
Positive
0
Negative
0
UnbrandedFR, GP
Sent
64
Opened
20
Clicked
9
Open / CTR
31.3%/14.1%
Positive
0
Negative
0
InaqoviES
Sent
63
Opened
13
Clicked
0
Open / CTR
20.6%/0.0%
Positive
0
Negative
0
RexultiES
Sent
62
Opened
38
Clicked
13
Open / CTR
61.3%/21.0%
Positive
0
Negative
0
Email #154
SF P2P Invite 7-May-26 [digital] v1UnspecifiedGB
Sent
61
Opened
26
Clicked
16
Open / CTR
42.6%/26.2%
Positive
0
Negative
0
LupkynisAT
Sent
58
Opened
10
Clicked
0
Open / CTR
17.2%/0.0%
Positive
0
Negative
0
Email #156
Aripiprazole 300mg PFS Available VAEAbilify MaintenaGB
Sent
58
Opened
27
Clicked
3
Open / CTR
46.6%/5.2%
Positive
0
Negative
0
RexultiIT
Sent
57
Opened
13
Clicked
6
Open / CTR
22.8%/10.5%
Positive
0
Negative
0
Email #158
IT Veeva Double Opt-In Remote MeetingsUnbrandedIT
Sent
57
Opened
33
Clicked
23
Open / CTR
57.9%/40.4%
Positive
0
Negative
0
Email #159
Postal Navidad 2025 - NefroLupkynisES
Sent
55
Opened
12
Clicked
1
Open / CTR
21.8%/1.8%
Positive
0
Negative
0
LupkynisAT
Sent
55
Opened
15
Clicked
6
Open / CTR
27.3%/10.9%
Positive
0
Negative
0
Email #161
Abilify 400_branded_AE SaTISfyAbilify MaintenaIT
Sent
55
Opened
13
Clicked
5
Open / CTR
23.6%/9.1%
Positive
0
Negative
0
InaqoviES
Sent
54
Opened
24
Clicked
15
Open / CTR
44.4%/27.8%
Positive
0
Negative
0
InaqoviDE
Sent
54
Opened
11
Clicked
4
Open / CTR
20.4%/7.4%
Positive
0
Negative
0
UnspecifiedES
Sent
53
Opened
24
Clicked
4
Open / CTR
45.3%/7.5%
Positive
0
Negative
0
LupkynisES
Sent
52
Opened
21
Clicked
1
Open / CTR
40.4%/1.9%
Positive
0
Negative
0
Email #166
Maintena Talks: webinar 24 febreroAbilify MaintenaES
Sent
52
Opened
39
Clicked
17
Open / CTR
75.0%/32.7%
Positive
0
Negative
0
Abilify MaintenaFR
Sent
52
Opened
21
Clicked
8
Open / CTR
40.4%/15.4%
Positive
0
Negative
0
RexultiIT
Sent
51
Opened
25
Clicked
4
Open / CTR
49.0%/7.8%
Positive
0
Negative
0
Email #169
LUP - Poster Deep Response - reumaLupkynisES
Sent
49
Opened
1
Clicked
0
Open / CTR
2.0%/0.0%
Positive
0
Negative
0
Email #170
INA VAE DE - Nachlese DGHO 2025 (Case)InaqoviDE
Sent
49
Opened
5
Clicked
0
Open / CTR
10.2%/0.0%
Positive
0
Negative
0
LupkynisAT
Sent
49
Opened
16
Clicked
10
Open / CTR
32.7%/20.4%
Positive
0
Negative
0
Email #172
Disclosure-Consent__Veeva-CRM__IT_email2UnbrandedGB, IT
Sent
48
Opened
28
Clicked
24
Open / CTR
58.3%/50.0%
Positive
0
Negative
0
LupkynisES
Sent
46
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
Email #174
UK - Consent Email 1 Aug 25UnbrandedGB
Sent
46
Opened
32
Clicked
26
Open / CTR
69.6%/56.5%
Positive
0
Negative
0
Email #175
Invitation RP Perspective(s)Abilify MaintenaFR
Sent
45
Opened
17
Clicked
5
Open / CTR
37.8%/11.1%
Positive
0
Negative
0
Email #176
IT Veeva Double Opt-In Market Med+SciUnbrandedIT
Sent
43
Opened
28
Clicked
23
Open / CTR
65.1%/53.5%
Positive
0
Negative
0
Abilify MaintenaES
Sent
43
Opened
26
Clicked
12
Open / CTR
60.5%/27.9%
Positive
0
Negative
0
InaqoviAT
Sent
43
Opened
12
Clicked
0
Open / CTR
27.9%/0.0%
Positive
0
Negative
0
InaqoviIT
Sent
42
Opened
19
Clicked
4
Open / CTR
45.2%/9.5%
Positive
0
Negative
0
Email #180
INA VAE AT GRIMALDI - EHA NL – VersandInaqoviAT
Sent
41
Opened
11
Clicked
0
Open / CTR
26.8%/0.0%
Positive
0
Negative
0
Email #181
AE SAFETY NEPHROLupkynisIT
Sent
41
Opened
12
Clicked
1
Open / CTR
29.3%/2.4%
Positive
0
Negative
0
Email #182
VAE DE AM960 - Switch Oral - 960_2025-09Abilify MaintenaDE
Sent
40
Opened
14
Clicked
4
Open / CTR
35.0%/10.0%
Positive
0
Negative
0
UnbrandedIT
Sent
40
Opened
22
Clicked
14
Open / CTR
55.0%/35.0%
Positive
0
Negative
0
Abilify MaintenaFR
Sent
40
Opened
19
Clicked
7
Open / CTR
47.5%/17.5%
Positive
0
Negative
0
Email #185
AM2M - Material adherenciaAbilify MaintenaES
Sent
39
Opened
13
Clicked
2
Open / CTR
33.3%/5.1%
Positive
0
Negative
0
LupkynisES
Sent
38
Opened
5
Clicked
1
Open / CTR
13.2%/2.6%
Positive
0
Negative
0
InaqoviAT
Sent
38
Opened
8
Clicked
0
Open / CTR
21.1%/0.0%
Positive
0
Negative
0
LupkynisAT
Sent
38
Opened
24
Clicked
15
Open / CTR
63.2%/39.5%
Positive
0
Negative
0
Email #189
VAE AT - Jinarc Grüne Box (Nephrologie)JinarcAT
Sent
37
Opened
5
Clicked
0
Open / CTR
13.5%/0.0%
Positive
0
Negative
0
InaqoviAT
Sent
37
Opened
7
Clicked
0
Open / CTR
18.9%/0.0%
Positive
0
Negative
0
InaqoviAT
Sent
37
Opened
1
Clicked
0
Open / CTR
2.7%/0.0%
Positive
0
Negative
0
LupkynisCH
Sent
36
Opened
17
Clicked
1
Open / CTR
47.2%/2.8%
Positive
0
Negative
0
LupkynisAT
Sent
36
Opened
10
Clicked
1
Open / CTR
27.8%/2.8%
Positive
0
Negative
0
Email #194
AE INAQOVI Informazioni clinicheInaqoviIT
Sent
36
Opened
13
Clicked
1
Open / CTR
36.1%/2.8%
Positive
0
Negative
0
LupkynisES
Sent
36
Opened
20
Clicked
2
Open / CTR
55.6%/5.6%
Positive
0
Negative
0
LupkynisCH
Sent
36
Opened
7
Clicked
0
Open / CTR
19.4%/0.0%
Positive
0
Negative
0
InaqoviES
Sent
34
Opened
5
Clicked
3
Open / CTR
14.7%/8.8%
Positive
2
Negative
0
LupkynisES
Sent
34
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
LupkynisCH
Sent
34
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
Email #200
AURORA 2 - AE NEPHROLupkynisIT
Sent
34
Opened
15
Clicked
2
Open / CTR
44.1%/5.9%
Positive
0
Negative
0
UnbrandedGB
Sent
33
Opened
21
Clicked
11
Open / CTR
63.6%/33.3%
Positive
0
Negative
0
Email #202
Italy - Consent Email Aug 25 v2UnbrandedIT
Sent
33
Opened
18
Clicked
11
Open / CTR
54.5%/33.3%
Positive
0
Negative
0
Email #203
Efficacia InaqoviInaqoviIT
Sent
32
Opened
13
Clicked
1
Open / CTR
40.6%/3.1%
Positive
0
Negative
0
InaqoviES
Sent
32
Opened
18
Clicked
10
Open / CTR
56.3%/31.3%
Positive
0
Negative
0
LupkynisES
Sent
31
Opened
17
Clicked
8
Open / CTR
54.8%/25.8%
Positive
0
Negative
0
LupkynisAT
Sent
31
Opened
11
Clicked
2
Open / CTR
35.5%/6.5%
Positive
0
Negative
0
UnspecifiedIT
Sent
30
Opened
22
Clicked
9
Open / CTR
73.3%/30.0%
Positive
10
Negative
2
RexultiES
Sent
29
Opened
20
Clicked
7
Open / CTR
69.0%/24.1%
Positive
0
Negative
0
LupkynisAT
Sent
29
Opened
12
Clicked
7
Open / CTR
41.4%/24.1%
Positive
0
Negative
0
LupkynisAT
Sent
29
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
Email #211
RXULTI - Eficaz y fácil de iniciarRexultiES
Sent
27
Opened
15
Clicked
5
Open / CTR
55.6%/18.5%
Positive
0
Negative
0
LupkynisAT
Sent
27
Opened
9
Clicked
4
Open / CTR
33.3%/14.8%
Positive
0
Negative
0
RexultiIT
Sent
27
Opened
8
Clicked
6
Open / CTR
29.6%/22.2%
Positive
0
Negative
0
Email #214
INA VAE DE - Case Report Thieme 03/26InaqoviDE
Sent
26
Opened
6
Clicked
4
Open / CTR
23.1%/15.4%
Positive
0
Negative
0
InaqoviES
Sent
23
Opened
17
Clicked
2
Open / CTR
73.9%/8.7%
Positive
0
Negative
0
RexultiES
Sent
23
Opened
11
Clicked
1
Open / CTR
47.8%/4.3%
Positive
0
Negative
0
InaqoviDE
Sent
23
Opened
10
Clicked
2
Open / CTR
43.5%/8.7%
Positive
0
Negative
0
Email #218
Disclosure-Consent__Veeva-CRM__UKUnbrandedGB, IE
Sent
23
Opened
19
Clicked
16
Open / CTR
82.6%/69.6%
Positive
0
Negative
0
LupkynisGB
Sent
23
Opened
9
Clicked
1
Open / CTR
39.1%/4.3%
Positive
0
Negative
0
Email #220
INA VAE DE - EHA NL – VersandInaqoviDE
Sent
22
Opened
9
Clicked
1
Open / CTR
40.9%/4.5%
Positive
0
Negative
0
Email #221
DK AM2 E-mail Kane video June 25 LU DRAAbilify MaintenaDK
Sent
22
Opened
6
Clicked
1
Open / CTR
27.3%/4.5%
Positive
0
Negative
0
Email #222
RXULTI - Monografía de productoRexultiES
Sent
21
Opened
14
Clicked
8
Open / CTR
66.7%/38.1%
Positive
0
Negative
0
Email #223
INA VAE AT EREP – EL OeGHO 2026 BregenzInaqoviAT
Sent
21
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
LupkynisAT
Sent
21
Opened
11
Clicked
2
Open / CTR
52.4%/9.5%
Positive
0
Negative
0
Abilify MaintenaDK
Sent
21
Opened
4
Clicked
1
Open / CTR
19.0%/4.8%
Positive
0
Negative
0
LupkynisIT
Sent
21
Opened
8
Clicked
1
Open / CTR
38.1%/4.8%
Positive
0
Negative
0
DawnzeraDE
Sent
21
Opened
8
Clicked
3
Open / CTR
38.1%/14.3%
Positive
0
Negative
0
LupkynisCH
Sent
20
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
Email #229
IT Veeva Double Opt-In Market ResearchUnbrandedIT
Sent
19
Opened
10
Clicked
6
Open / CTR
52.6%/31.6%
Positive
0
Negative
0
RexultiIT
Sent
19
Opened
6
Clicked
2
Open / CTR
31.6%/10.5%
Positive
0
Negative
0
Abilify MaintenaES
Sent
18
Opened
7
Clicked
0
Open / CTR
38.9%/0.0%
Positive
0
Negative
0
Email #232
AE Il ruolo del caregiverInaqoviIT
Sent
18
Opened
5
Clicked
2
Open / CTR
27.8%/11.1%
Positive
0
Negative
0
Email #233
AE Inaqovi: ipometilante oraleInaqoviIT
Sent
18
Opened
7
Clicked
2
Open / CTR
38.9%/11.1%
Positive
0
Negative
0
RexultiES
Sent
17
Opened
8
Clicked
2
Open / CTR
47.1%/11.8%
Positive
0
Negative
0
UnbrandedGB
Sent
17
Opened
13
Clicked
8
Open / CTR
76.5%/47.1%
Positive
0
Negative
0
Abilify MaintenaDE
Sent
16
Opened
14
Clicked
7
Open / CTR
87.5%/43.8%
Positive
0
Negative
0
LupkynisES
Sent
15
Opened
4
Clicked
2
Open / CTR
26.7%/13.3%
Positive
0
Negative
0
Email #238
SE_MiniKampanj_960mg_preapprovedAbilify MaintenaSE
Sent
14
Opened
6
Clicked
0
Open / CTR
42.9%/0.0%
Positive
0
Negative
0
Email #239
AURORA 2 - AE RHEUMALupkynisIT
Sent
14
Opened
1
Clicked
1
Open / CTR
7.1%/7.1%
Positive
0
Negative
0
UnbrandedIT
Sent
14
Opened
7
Clicked
5
Open / CTR
50.0%/35.7%
Positive
0
Negative
0
Abilify MaintenaFR
Sent
14
Opened
7
Clicked
0
Open / CTR
50.0%/0.0%
Positive
0
Negative
0
LupkynisIT
Sent
13
Opened
4
Clicked
0
Open / CTR
30.8%/0.0%
Positive
0
Negative
0
Email #243
Le ragioni per scegliere INAQOVIInaqoviIT
Sent
13
Opened
5
Clicked
1
Open / CTR
38.5%/7.7%
Positive
0
Negative
0
Email #244
Remerciement RP "Perspective(s)"Abilify MaintenaFR
Sent
13
Opened
7
Clicked
1
Open / CTR
53.8%/7.7%
Positive
0
Negative
0
UnspecifiedIT
Sent
13
Opened
2
Clicked
0
Open / CTR
15.4%/0.0%
Positive
0
Negative
0
Email #246
INAQOVI VAE DE - FOMF Webinar 30.09.2025InaqoviDE
Sent
12
Opened
2
Clicked
1
Open / CTR
16.7%/8.3%
Positive
0
Negative
0
LupkynisCH
Sent
12
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
Abilify MaintenaSE
Sent
12
Opened
4
Clicked
0
Open / CTR
33.3%/0.0%
Positive
0
Negative
0
Abilify MaintenaIT
Sent
12
Opened
4
Clicked
1
Open / CTR
33.3%/8.3%
Positive
0
Negative
0
RexultiES
Sent
11
Opened
5
Clicked
0
Open / CTR
45.5%/0.0%
Positive
0
Negative
0
Abilify MaintenaDE
Sent
11
Opened
6
Clicked
2
Open / CTR
54.5%/18.2%
Positive
0
Negative
0
UnbrandedAT, DE, ZZ
Sent
11
Opened
5
Clicked
4
Open / CTR
45.5%/36.4%
Positive
0
Negative
0
Email #253
ALL_Launch_960mg_2025_AM_deAbilify MaintenaCH
Sent
11
Opened
6
Clicked
0
Open / CTR
54.5%/0.0%
Positive
0
Negative
0
LupkynisCH
Sent
11
Opened
6
Clicked
2
Open / CTR
54.5%/18.2%
Positive
0
Negative
0
LupkynisAT
Sent
11
Opened
1
Clicked
0
Open / CTR
9.1%/0.0%
Positive
0
Negative
0
InaqoviIT
Sent
11
Opened
4
Clicked
0
Open / CTR
36.4%/0.0%
Positive
0
Negative
0
Email #257
Postal Navidad 2025 - ReumaLupkynisES
Sent
10
Opened
2
Clicked
0
Open / CTR
20.0%/0.0%
Positive
0
Negative
0
LupkynisCH
Sent
10
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
LupkynisGB
Sent
10
Opened
4
Clicked
0
Open / CTR
40.0%/0.0%
Positive
0
Negative
0
LupkynisIT
Sent
10
Opened
4
Clicked
0
Open / CTR
40.0%/0.0%
Positive
0
Negative
0
UnspecifiedIT
Sent
10
Opened
3
Clicked
0
Open / CTR
30.0%/0.0%
Positive
0
Negative
0
Abilify MaintenaCH
Sent
9
Opened
3
Clicked
0
Open / CTR
33.3%/0.0%
Positive
0
Negative
0
Email #263
AE Riduzione del burden di trattamentoInaqoviIT
Sent
9
Opened
3
Clicked
0
Open / CTR
33.3%/0.0%
Positive
0
Negative
0
RexultiIT
Sent
9
Opened
6
Clicked
1
Open / CTR
66.7%/11.1%
Positive
0
Negative
0
Email #265
INVITATION_RDV TEL_092022UnbrandedFR
Sent
9
Opened
5
Clicked
0
Open / CTR
55.6%/0.0%
Positive
0
Negative
0
InaqoviES
Sent
9
Opened
3
Clicked
1
Open / CTR
33.3%/11.1%
Positive
0
Negative
0
UnspecifiedIT
Sent
9
Opened
2
Clicked
0
Open / CTR
22.2%/0.0%
Positive
0
Negative
0
UnspecifiedAT
Sent
9
Opened
2
Clicked
0
Open / CTR
22.2%/0.0%
Positive
0
Negative
0
Email #269
VAE - Manuscrito SECARexultiES
Sent
8
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
Email #270
INA VAE DE - EHA 2025 Otsuka SymposiumInaqoviDE
Sent
8
Opened
5
Clicked
3
Open / CTR
62.5%/37.5%
Positive
4
Negative
4
Email #271
AE EFFICACY NEPHROLupkynisIT
Sent
8
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
RexultiIT
Sent
8
Opened
6
Clicked
3
Open / CTR
75.0%/37.5%
Positive
0
Negative
0
UnbrandedFR
Sent
8
Opened
5
Clicked
1
Open / CTR
62.5%/12.5%
Positive
0
Negative
0
Email #274
France - Opt In Email Aug 25UnbrandedFR
Sent
8
Opened
5
Clicked
0
Open / CTR
62.5%/0.0%
Positive
0
Negative
0
UnspecifiedAT
Sent
8
Opened
2
Clicked
0
Open / CTR
25.0%/0.0%
Positive
0
Negative
0
SibeprenlimabES
Sent
7
Opened
6
Clicked
0
Open / CTR
85.7%/0.0%
Positive
0
Negative
0
Email #277
Germany Consent Email - Aug25 v2UnbrandedDE
Sent
7
Opened
5
Clicked
3
Open / CTR
71.4%/42.9%
Positive
0
Negative
0
Email #278
Austria - Consent Email - Aug25UnbrandedAT
Sent
7
Opened
3
Clicked
1
Open / CTR
42.9%/14.3%
Positive
0
Negative
0
InaqoviAT
Sent
7
Opened
2
Clicked
0
Open / CTR
28.6%/0.0%
Positive
0
Negative
0
Email #280
Netherlands - Opt in Email Aug 25UnbrandedDK, NO, SE
Sent
7
Opened
5
Clicked
5
Open / CTR
71.4%/71.4%
Positive
0
Negative
0
Email #281
AE TIS Aggiornata OPITAbilify MaintenaIT
Sent
7
Opened
2
Clicked
1
Open / CTR
28.6%/14.3%
Positive
0
Negative
0
Email #282
Germany Consent Email v4UnspecifiedAT, DE
Sent
7
Opened
5
Clicked
5
Open / CTR
71.4%/71.4%
Positive
0
Negative
0
Email #283
Curso residentes HSJD: programaUnspecifiedES
Sent
7
Opened
3
Clicked
3
Open / CTR
42.9%/42.9%
Positive
0
Negative
0
UnspecifiedIT
Sent
7
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
RexultiES
Sent
6
Opened
2
Clicked
0
Open / CTR
33.3%/0.0%
Positive
1
Negative
0
Email #286
Disclosure-Consent__Veeva-CRM__DEUnbrandedDE
Sent
6
Opened
2
Clicked
1
Open / CTR
33.3%/16.7%
Positive
0
Negative
0
Email #287
INA VAE DE - Ein- und UmstellungInaqoviDE
Sent
6
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
Abilify MaintenaCH
Sent
6
Opened
3
Clicked
1
Open / CTR
50.0%/16.7%
Positive
0
Negative
0
LupkynisAT
Sent
6
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
Email #290
Disclosure-Consent__Veeva-CRM__SEUnbrandedFI, SE
Sent
6
Opened
5
Clicked
3
Open / CTR
83.3%/50.0%
Positive
0
Negative
0
Email #291
AE EFFICACY RHEUMALupkynisIT
Sent
6
Opened
2
Clicked
0
Open / CTR
33.3%/0.0%
Positive
0
Negative
0
UnbrandedFR
Sent
6
Opened
3
Clicked
2
Open / CTR
50.0%/33.3%
Positive
0
Negative
0
RexultiES
Sent
5
Opened
4
Clicked
2
Open / CTR
80.0%/40.0%
Positive
0
Negative
0
Email #294
Disclosure-Consent__Veeva-CRM__ATUnbrandedAT, DE, ZZ
Sent
5
Opened
4
Clicked
3
Open / CTR
80.0%/60.0%
Positive
0
Negative
0
LupkynisAT
Sent
5
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
LupkynisIT
Sent
5
Opened
2
Clicked
0
Open / CTR
40.0%/0.0%
Positive
0
Negative
0
InaqoviES
Sent
5
Opened
3
Clicked
2
Open / CTR
60.0%/40.0%
Positive
0
Negative
0
Email #298
CNS - Porfolio OtsukaRexultiES
Sent
4
Opened
3
Clicked
1
Open / CTR
75.0%/25.0%
Positive
0
Negative
0
InaqoviES
Sent
4
Opened
4
Clicked
3
Open / CTR
100.0%/75.0%
Positive
0
Negative
0
Email #300
MENTORA Reunión enfermería 13-14 FebreroAbilify MaintenaES
Sent
4
Opened
3
Clicked
2
Open / CTR
75.0%/50.0%
Positive
0
Negative
0
UnbrandedDE, ZZ
Sent
4
Opened
3
Clicked
3
Open / CTR
75.0%/75.0%
Positive
0
Negative
0
LupkynisCH
Sent
4
Opened
1
Clicked
1
Open / CTR
25.0%/25.0%
Positive
0
Negative
0
LupkynisCH
Sent
4
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
InaqoviAT
Sent
4
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
LupkynisAT
Sent
4
Opened
2
Clicked
1
Open / CTR
50.0%/25.0%
Positive
0
Negative
0
InaqoviAT
Sent
4
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
Email #307
SF P2P Invite 23-Feb-26 [digital]Abilify MaintenaGB
Sent
4
Opened
2
Clicked
1
Open / CTR
50.0%/25.0%
Positive
0
Negative
0
Email #308
SE_preapproved_email_Pillinger2025Abilify MaintenaSE
Sent
4
Opened
2
Clicked
0
Open / CTR
50.0%/0.0%
Positive
0
Negative
0
Abilify MaintenaDK
Sent
4
Opened
3
Clicked
3
Open / CTR
75.0%/75.0%
Positive
0
Negative
0
UnbrandedDK, LU, NL
Sent
4
Opened
2
Clicked
0
Open / CTR
50.0%/0.0%
Positive
0
Negative
0
InaqoviES
Sent
4
Opened
3
Clicked
2
Open / CTR
75.0%/50.0%
Positive
0
Negative
0
Email #312
ALL_Zielpatient_2026_AM_AA_deAbilify MaintenaCH
Sent
4
Opened
2
Clicked
0
Open / CTR
50.0%/0.0%
Positive
0
Negative
0
UnspecifiedIT
Sent
4
Opened
1
Clicked
1
Open / CTR
25.0%/25.0%
Positive
0
Negative
0
Email #314
AM2M - AGUDOSAbilify MaintenaES
Sent
3
Opened
1
Clicked
0
Open / CTR
33.3%/0.0%
Positive
0
Negative
0
Email #315
ENFERMERÍA - Curso acreditado RETO TMGRexultiES
Sent
3
Opened
2
Clicked
1
Open / CTR
66.7%/33.3%
Positive
0
Negative
0
Email #316
ENFERMERíA - PODCAST Ep3 AlimentaciónRexultiES
Sent
3
Opened
1
Clicked
1
Open / CTR
33.3%/33.3%
Positive
0
Negative
0
Email #317
Swiss German - Consent Email Aug25 v2UnbrandedCH, DE
Sent
3
Opened
3
Clicked
3
Open / CTR
100.0%/100.0%
Positive
0
Negative
0
Abilify MaintenaDE
Sent
3
Opened
3
Clicked
0
Open / CTR
100.0%/0.0%
Positive
0
Negative
0
LupkynisAT
Sent
3
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
LupkynisAT
Sent
3
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
LupkynisAT
Sent
3
Opened
1
Clicked
0
Open / CTR
33.3%/0.0%
Positive
0
Negative
0
LupkynisAT
Sent
3
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
LupkynisAT
Sent
3
Opened
2
Clicked
0
Open / CTR
66.7%/0.0%
Positive
0
Negative
0
Abilify MaintenaSE
Sent
3
Opened
3
Clicked
0
Open / CTR
100.0%/0.0%
Positive
0
Negative
0
Abilify MaintenaDK
Sent
3
Opened
2
Clicked
1
Open / CTR
66.7%/33.3%
Positive
0
Negative
0
Email #326
Inaqovi indicazione e somministrazioneInaqoviIT
Sent
3
Opened
1
Clicked
0
Open / CTR
33.3%/0.0%
Positive
0
Negative
0
Abilify MaintenaIT
Sent
3
Opened
1
Clicked
0
Open / CTR
33.3%/0.0%
Positive
0
Negative
0
RexultiIT
Sent
3
Opened
1
Clicked
0
Open / CTR
33.3%/0.0%
Positive
0
Negative
0
Email #329
Denmark- Opt In Email Aug25UnbrandedNO, SE
Sent
3
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
DawnzeraDE
Sent
3
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
Email #331
AE SAFETY RHEUMALupkynisIT
Sent
3
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
Email #332
AE - MOA LUPKYNIS - IMMUNOLupkynisIT
Sent
3
Opened
2
Clicked
0
Open / CTR
66.7%/0.0%
Positive
0
Negative
0
Email #333
INVITATION VAD 2026 DAWNZERAUnspecifiedFR
Sent
3
Opened
1
Clicked
0
Open / CTR
33.3%/0.0%
Positive
0
Negative
0
UnspecifiedIT
Sent
3
Opened
1
Clicked
0
Open / CTR
33.3%/0.0%
Positive
0
Negative
0
Email #335
AM2M - Valor clínicoAbilify MaintenaES
Sent
2
Opened
1
Clicked
0
Open / CTR
50.0%/0.0%
Positive
0
Negative
0
RexultiES
Sent
2
Opened
1
Clicked
1
Open / CTR
50.0%/50.0%
Positive
0
Negative
0
Email #337
RXULTI: Mecanismo de acción únicoRexultiES
Sent
2
Opened
1
Clicked
0
Open / CTR
50.0%/0.0%
Positive
0
Negative
0
InaqoviDE
Sent
2
Opened
1
Clicked
0
Open / CTR
50.0%/0.0%
Positive
0
Negative
0
Abilify MaintenaCH
Sent
2
Opened
1
Clicked
1
Open / CTR
50.0%/50.0%
Positive
0
Negative
0
UnbrandedCH
Sent
2
Opened
1
Clicked
1
Open / CTR
50.0%/50.0%
Positive
0
Negative
0
LupkynisCH
Sent
2
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
LupkynisCH
Sent
2
Opened
1
Clicked
1
Open / CTR
50.0%/50.0%
Positive
0
Negative
0
LupkynisAT
Sent
2
Opened
1
Clicked
0
Open / CTR
50.0%/0.0%
Positive
0
Negative
0
LupkynisAT
Sent
2
Opened
1
Clicked
0
Open / CTR
50.0%/0.0%
Positive
0
Negative
0
LupkynisAT
Sent
2
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
UnbrandedBE
Sent
2
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
Email #347
DEM 1 Psy/neurologo MoARexultiIT
Sent
2
Opened
1
Clicked
0
Open / CTR
50.0%/0.0%
Positive
0
Negative
0
Email #348
Linee guida KDIGO 2024 - NEPHROLupkynisIT
Sent
2
Opened
1
Clicked
0
Open / CTR
50.0%/0.0%
Positive
0
Negative
0
Email #349
RXULTI® AE Nuova ConfezioneRexultiIT
Sent
2
Opened
1
Clicked
0
Open / CTR
50.0%/0.0%
Positive
0
Negative
0
UnbrandedFR
Sent
2
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
InaqoviDE
Sent
2
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
Email #352
Linee guida KDIGO 2024 - RHEUMALupkynisIT
Sent
2
Opened
2
Clicked
0
Open / CTR
100.0%/0.0%
Positive
0
Negative
0
Email #353
VAE AT E-REP - SoftConsent (Nephrologie)LupkynisAT
Sent
2
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
UnspecifiedIT
Sent
2
Opened
1
Clicked
0
Open / CTR
50.0%/0.0%
Positive
0
Negative
0
Email #355
LUP - VAE Póster Adelphi - NefroUnspecifiedES
Sent
2
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
Email #356
LUP - VAE Póster Adelphi - ReumaUnspecifiedES
Sent
2
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
InaqoviES
Sent
1
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
Email #358
¿Conoces RXULTI?RexultiES
Sent
1
Opened
1
Clicked
0
Open / CTR
100.0%/0.0%
Positive
0
Negative
0
Abilify MaintenaES
Sent
1
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
Email #360
AM2M - ENFERMERÍA - Vídeo simpo AEESMEAbilify MaintenaES
Sent
1
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
Email #361
ENFERMERíA - PODCAST: Ep5 AutoestimaRexultiES
Sent
1
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
UnbrandedES
Sent
1
Opened
1
Clicked
0
Open / CTR
100.0%/0.0%
Positive
0
Negative
0
Email #363
FH - Curso Fundamentos SCZ APARexultiES
Sent
1
Opened
1
Clicked
0
Open / CTR
100.0%/0.0%
Positive
0
Negative
0
Email #364
FH - Curso IA en SaludRexultiES
Sent
1
Opened
1
Clicked
0
Open / CTR
100.0%/0.0%
Positive
0
Negative
0
Email #365
Peplau - Registro a la webAbilify MaintenaES
Sent
1
Opened
1
Clicked
1
Open / CTR
100.0%/100.0%
Positive
0
Negative
0
RexultiES
Sent
1
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
Abilify MaintenaDE
Sent
1
Opened
1
Clicked
0
Open / CTR
100.0%/0.0%
Positive
0
Negative
0
Abilify MaintenaDE
Sent
1
Opened
1
Clicked
0
Open / CTR
100.0%/0.0%
Positive
0
Negative
0
InaqoviDE
Sent
1
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
Email #370
VAE DE AM720 - Launch 04/25Abilify MaintenaDE
Sent
1
Opened
1
Clicked
0
Open / CTR
100.0%/0.0%
Positive
0
Negative
0
Email #371
ALL_Mode_of_Action_960mg_2025_AA_frAbilify MaintenaCH
Sent
1
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
UnbrandedCH
Sent
1
Opened
1
Clicked
1
Open / CTR
100.0%/100.0%
Positive
0
Negative
0
LupkynisCH
Sent
1
Opened
1
Clicked
1
Open / CTR
100.0%/100.0%
Positive
0
Negative
0
SamscaCH
Sent
1
Opened
1
Clicked
0
Open / CTR
100.0%/0.0%
Positive
0
Negative
0
LupkynisCH
Sent
1
Opened
1
Clicked
0
Open / CTR
100.0%/0.0%
Positive
0
Negative
0
LupkynisCH
Sent
1
Opened
1
Clicked
1
Open / CTR
100.0%/100.0%
Positive
0
Negative
0
InaqoviAT
Sent
1
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
InaqoviAT
Sent
1
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
InaqoviAT
Sent
1
Opened
1
Clicked
0
Open / CTR
100.0%/0.0%
Positive
0
Negative
0
LupkynisAT
Sent
1
Opened
1
Clicked
0
Open / CTR
100.0%/0.0%
Positive
0
Negative
0
LupkynisAT
Sent
1
Opened
1
Clicked
0
Open / CTR
100.0%/0.0%
Positive
0
Negative
0
LupkynisAT
Sent
1
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
Email #383
VAE AT E-REP - 3g UPCR (Nephrologie)LupkynisAT
Sent
1
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
LupkynisAT
Sent
1
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
LupkynisAT
Sent
1
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
LupkynisAT
Sent
1
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
LupkynisGB
Sent
1
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
UnbrandedFI
Sent
1
Opened
1
Clicked
0
Open / CTR
100.0%/0.0%
Positive
0
Negative
0
Abilify MaintenaSE
Sent
1
Opened
1
Clicked
0
Open / CTR
100.0%/0.0%
Positive
0
Negative
0
UnbrandedNL
Sent
1
Opened
1
Clicked
0
Open / CTR
100.0%/0.0%
Positive
0
Negative
0
UnbrandedNL
Sent
1
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
UnbrandedDK
Sent
1
Opened
1
Clicked
0
Open / CTR
100.0%/0.0%
Positive
0
Negative
0
UnbrandedFR
Sent
1
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
InaqoviAT
Sent
1
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
Email #395
ASEPP 2026: Programa simposio AlianzaRexultiES
Sent
1
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
Email #396
FR Veeva Privacy Notice EmailUnbrandedFR
Sent
1
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
Email #397
INA - Monografía InaqoviInaqoviES
Sent
1
Opened
1
Clicked
0
Open / CTR
100.0%/0.0%
Positive
0
Negative
0
InaqoviAT
Sent
1
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
LupkynisCH
Sent
1
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
InaqoviAT
Sent
1
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
UnspecifiedAT
Sent
1
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
Email #402
Aripiprazole 960mg Patient Material VAEUnspecifiedGB
Sent
1
Opened
1
Clicked
1
Open / CTR
100.0%/100.0%
Positive
0
Negative
0
Email #403
AE - MOA LUPKYNIS - RHEUMAUnspecifiedIT
Sent
1
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
Email #404
REMERCIEMENTS VAD DAWNZERA 2026UnspecifiedFR
Sent
1
Opened
1
Clicked
1
Open / CTR
100.0%/100.0%
Positive
0
Negative
0
Email #405
Belgium - Opt In Email Aug25UnspecifiedDK
Sent
1
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
UnspecifiedIT
Sent
1
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
UnspecifiedIT
Sent
1
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
Email #408
SIB - VAE Invitación simposio ERA 2026UnspecifiedES
Sent
1
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
UnspecifiedES
Sent
1
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0
UnspecifiedAT
Sent
1
Opened
0
Clicked
0
Open / CTR
0.0%/0.0%
Positive
0
Negative
0